Specialised Follow-up May Be Unnecessary for Low-Risk Chronic Leukaemia
1 Mins
Study shows it is feasible and safe to end specialised follow-up for patients with chronic lymphocytic leukaemia, optimising resources, maintaining survival rates, and reducing hospital visits.